Jeff Dykan - Feb 22, 2022 Form 4 Insider Report for ReWalk Robotics Ltd. (RWLK)

Role
Director
Signature
/s/ Ori Gon as attorney-in-fact
Stock symbol
RWLK
Transactions as of
Feb 22, 2022
Transactions value $
-$1,210
Form type
4
Date filed
2/24/2022, 03:30 PM
Previous filing
Nov 23, 2021
Next filing
Jun 30, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RWLK Ordinary Shares, par value NIS 0.25 per share Tax liability -$1.21K -1.1K -9.39% $1.10 10.6K Feb 22, 2022 Direct F1, F2, F3
holding RWLK Ordinary Shares, par value NIS 0.25 per share 65.7K Feb 22, 2022 By Partnership F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Ordinary Shares sold in the open market on February 22, 2022, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan.
F2 Market price per share of ReWalk Robotics Ltd.'s (the "Company's") Ordinary Shares on the transaction date.
F3 Prior to fiscal year 2021, the Reporting Person immediately and automatically assigned all Ordinary Shares underlying equity awards issued to the Reporting Person by the Company to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Ordinary Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Company with the permission of SCP. No Ordinary Shares were assigned to SCP by the Reporting Person after fiscal year 2020. This Form 4 reflects the Reporting Person's corrected direct and indirect beneficial ownership of Ordinary Shares as of the filing date.
F4 Based on information provided by the Reporting Person and SCP. Includes 50,488 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P., a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P., a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that SCP, through certain of its affiliates, has the right to acquire from IIA. The Reporting Person is therefore deemed to beneficially own 65,655 Ordinary Shares of the Company.